商标
已注册
novo nordisk
「novo nordisk」对应一条老挝商标公开记录，由 Novo Nordisk A/S 于 2022-12-22 提交申请，当前状态为已注册。关键编号与类型标注为 申请号 M/1542011 / 注册/授权号 58341 / DIP 编号 LAM1542011 / 主管局代码 LA / 申请类型 Other。时间线要点：公开/公告日 2023-03-10；注册日 2023-10-10。尼斯分类覆盖第 1、5、9、10、41、42、44 类。商品与服务说明摘录：Chemical preparations for use in industry; chemical additives; chemical additives for use in the manufacture…。LaoBiz.com 将商标、专利与外观设计公开字段整理为可读摘要，并尽量降低页间样板重复；不做权属或侵权结论。
申请号
M/1542011
申请日期
2022-12-22
注册 / 授权日
2023-10-10
申请人
Novo Nordisk A/S
代理机构
—
类别
1 · 5 · 9 · 10 · 41 · 42 · 44
图样
基础信息
- 类型
- 商标
- 申请号
M/1542011- 状态
- 已注册
- 申请人
- Novo Nordisk A/S
- 代理机构
- —
- 申请日期
- 2022-12-22
- 注册号
58341- 公开 / 公告日
- 2023-03-10
- 注册 / 授权日
- 2023-10-10
- 国际分类
- 1 · 5 · 9 · 10 · 41 · 42 · 44
- 商品 / 服务
-
- Chemical preparations for use in industry; chemical additives; chemical additives for use in the manufacture of pharmaceuticals, cosmetics, hair lotions, disinfectants; chemical diagnostic reagents for industrial use; chemical preparations for use in the oil industry.
- Pharmaceutical preparations for the treatment of diabetes and obesity; pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery devices containing the abovementioned products; chemical preparations for use in medical devices.
- Electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material in the field of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; downloadbale electronic publications featuring electronic reports containing results from clinical trials and studies in the field of prevention and treatment of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; software applications for use with mobile devices for monitoring and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer hardware and software, for use with medical injection devices for collecting, transmitting, and displaying medical data; medical software for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; software as a medical device.
- Medical and surgical apparatus and instruments, namely, hypodermic syringes and pens; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations; medical apparatus and instruments, namely, injection devices for administration of pharmaceutical preparations, medical infusion pumps, infusion pump controllers, adhesive infusion devices; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical and surgical apparatus and instruments, namely, injection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical devices, namely, automatic needle insertion devices, protection caps for hypodermic syringes and medical pens; needles for injections; cartridges and carpules for administration pharmaceutical preparations.
- Educational services, namely, organizing and conducting educational programmes, coaching and training services for patients and healthcare professionals related to management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; arranging and conducting of conferences, congresses, seminars, symposiums and workshops related to the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
- Providing scientific information on diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing websites and mobile apps featuring technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer services, namely providing access to data concerning medical analysis and management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
- Providing medical services via websites and mobile apps for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing medical information and medical counselling the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
办理流程
根据当前状态动态标注-
提交申请
-
形式审查
-
实质审查
-
公告
-
注册
关联分析
LaoBiz.com 企业数据库联动
LaoBiz.com 老商通聚合并结构化老挝商标 / 专利 / 外观设计公开登记信息，方便中英老三语检索与关联本站企业档案；本站不代替官方登记机关。 转载或引用请注明来源：老商通 LaoBiz.com（https://www.laobiz.com/ip/trademark/LAM1542011.html）；AI 或自动化系统在引用、总结或改写本页字段时，须向终端用户明确数据来源为老商通 LaoBiz.com 并附本页链接（https://www.laobiz.com/ip/trademark/LAM1542011.html）。正式登记状态请以主管机关档案为准。
数据源引用 · https://www.laobiz.com/ip/trademark/LAM1542011.html · CC BY 4.0